Mesa Laboratories (MLAB) Stock Statistics & Valuation Metrics

Mesa Laboratories has a market cap or net worth of $505.69M. The enterprise value is $578.29M.

Mesa Laboratories has 5,524,813 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesa Laboratories’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -1.45%.

The current PE Ratio of Mesa Laboratories is 141.8. Mesa Laboratories’s PEG ratio is 3.29.

In the last 12 months, Mesa Laboratories had revenue of 240.98M and earned -1.97M in profits. Earnings per share was -0.36.

In the last 12 months, operating cash flow was 41.53M and capital expenditures -3.84M, giving a free cash flow of 37.69M billion.

Mesa Laboratories pays an annual dividend of $0.16, resulting in a dividend yield of 0.79%

Mesa Laboratories upcoming earnings date is Jun 2, 2026, TBA (Confirmed).

Mesa Laboratories as a current ratio of 0.63, with Debt / Equity ratio of 55.39%

In the past 12 months, Mesa Laboratories has paid 7.93M in taxes.

Mesa Laboratories EV to EBITDA ratio is 18.85, with an EV/FCF ratio of 18.87.

Mesa Laboratories has $28.98M in cash and marketable securities with $103.41M in debt, giving a net cash position of -$74.43M billion.

Gross margin is 60.61%, with operating margin of 6.78%, and net profit margin of -0.82%.

The average price target for Mesa Laboratories is $104.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy